Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001041062-23-000182
Filing Date
2023-12-08
Accepted
2023-12-08 13:18:35
Documents
1
Group Members
BRANDES INVESTMENT PARTNERS, L.P.BRANDES WORLDWIDE HOLDINGS, L.P.GLENN CARLSON

Document Format Files

Seq Description Document Type Size
1 13G Phibro_Animal_Health.txt SC 13G 11512
  Complete submission text file 0001041062-23-000182.txt   13563
Mailing Address 4275 EXECUTIVE SQUARE 5TH FLOOR LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE 5TH FLOOR LA JOLLA CA 92037 8587550239
BRANDES INVESTMENT PARTNERS, LP (Filed by) CIK: 0001015079 (see all company filings)

EIN.: 330704072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Subject) CIK: 0001069899 (see all company filings)

EIN.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SC 13G | Act: 34 | File No.: 005-88114 | Film No.: 231474844
SIC: 2834 Pharmaceutical Preparations